After Completing the Registration Process, your Biography will be displayed here.
Register by using your Entry ID: 1708
Register by using your Entry ID: 1708
Dr. Claudio Villota Arcos is a researcher specializing in cellular and molecular biology, with a strong interdisciplinary focus on cancer biology, mitochondrial genetics, virology, and nutrition-related molecular mechanisms. His research centers on the role of mitochondrial non-coding RNAs in cancer initiation, progression, and therapeutic targeting, alongside emerging interests in viral oncogenesis, metabolic regulation, and inflammation-linked diseases. Dr. Villota Arcos serves as an academic researcher at the School of Nutrition and Dietetics, Universidad Bernardo O’Higgins, where he integrates molecular biology with translational health research. His key contributions include pioneering discoveries on antisense mitochondrial non-coding RNAs as selective vulnerabilities in cancer cells, advancing novel molecular targets for cancer therapy, and influencing diagnostic and therapeutic research strategies. His impact vision emphasizes translating fundamental mitochondrial biology into clinically relevant innovations, strengthening precision oncology approaches, and bridging molecular science with public health and nutritional interventions for global disease prevention.
700
400
50
0
View Google Scholar
View Scopus profile View ORCID profile
Prof. Dr.Reinhard Heinz Hans Neubert is a leading researcher specializing in dermal drug delivery and dermatopharmaceutical sciences, currently affiliated with the Institute of Applied Dermatopharmacy (IADP), Martin Luther University Halle-Wittenberg. His research focuses on dermal and transdermal drug delivery systems, nanostructure and organization of stratum corneum lipids, ceramide chemistry, colloidal carrier systems, phytopharmaceuticals, and the application of affinity capillary electrophoresis to optimize topical formulations. With extensive academic and translational experience, he has led large-scale collaborative research initiatives and advised numerous postgraduate researchers while also contributing to industry-oriented innovation through consultancy and technology transfer. His key contributions include pioneering insights into skin barrier lipid organization, advancement of analytical methods for skin penetration studies, and the development of innovative dermal delivery platforms supported by multiple patents. Impact Vision: Prof. Neubert’s work strengthens the scientific foundation of skin barrier research and accelerates the translation of dermatological innovations into effective, safe, and globally relevant therapeutic and cosmetic solutions.
14000
1000
600
500
0
View Scopus Profile
View ORCID profile
Dr. Kai-An Chuang is a biomedical researcher specializing in pharmacodynamics, toxicology, and advanced bioactive product development, with strong translational expertise bridging laboratory science and industry innovation. His research focuses on neuroprotection, immunomodulation, natural bioactive compounds, extracellular vesicles, and plant-derived therapeutics, with emerging interests in cosmetic and biomedical applications of exosome-like nanoparticles. He currently serves as Technical Assistant Manager at PEGAVISION Corporation and Facial Beau International Corp., where he leads advanced product R&D, and previously worked as a Researcher at the Industrial Technology Research Institute (ITRI) in Taiwan. Dr. Chuang has made significant contributions through mechanistic discoveries in neuroinflammation, immune regulation, and natural compound–based interventions, supporting both therapeutic and commercial translation. His impact vision centers on transforming bioactive natural resources into clinically and industrially relevant solutions, advancing human health, sustainable biotechnology, and global innovation through evidence-based research and cross-sector collaboration.
Prof. Pradyuman Kumar Baranwal is a Professor in Food Engineering and Technology at Sant Longowal Institute of Engineering and Technology (SLIET), India. His research expertise spans food formulation, food powders, spray drying, functional foods, nutraceuticals, and ready-to-eat (RTE) foods. He has published extensively in high-impact international journals, with over 100 peer-reviewed publications and more than 5,000 citations, reflecting significant scholarly influence. His work emphasizes process optimization, value addition of cereals and millets, and development of functional food ingredients, contributing to improved food quality, nutrition security, and sustainable utilization of agricultural resources through interdisciplinary and collaborative research.
8000
6000
200
0
View Google Scholar
View ORCID profile View Scopus profile
Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.
1500
1000
600
0
Prof. Marcelo Fabiano Gomes Boriollo is a senior researcher specializing in Medical and Oral Microbiology, with strong expertise in molecular epidemiology, microbial genetics, biofilms, and antimicrobial pharmacology. His research focus centers on the pathogenicity, genotyping, and virulence mechanisms of microorganisms such as Candida spp., Staphylococcus spp., and Enterobacteria, alongside emerging studies on natural products, phytotherapy, and nanoparticle-based antimicrobial strategies. He has held key academic and research positions at leading Brazilian institutions, including Universidade Federal de São Carlos, Universidade Estadual de Campinas, and Universidade José do Rosário Vellano, contributing extensively to research leadership and postgraduate mentoring. Prof. Boriollo’s major contributions include high-impact discoveries in microbial genotyping, biofilm control, antifungal and antibacterial innovations, and the application of natural compounds and nanomaterials against resistant pathogens. His impact vision emphasizes translating microbiological research into clinically relevant solutions, strengthening infection control, advancing public health, and fostering innovation at the interface of microbiology, dentistry, and biomedical sciences.
1000
500
200
100
0
View ORCID Profile View Scopus Profile
Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.
80
60
20
0